Form 8-K - Current report:
SEC Accession No. 0001387131-19-007419
Filing Date
2019-10-03
Accepted
2019-10-03 17:03:49
Documents
5
Period of Report
2019-10-02
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nbse-8k_100219.htm 8-K 31398
2 LETTER FROM MALONEBAILEY, LLP, DATED OCTOBER 3, 2019 ex16-1.htm EX-16.1 3955
3 GRAPHIC ex16-1_img001.jpg GRAPHIC 19469
4 GRAPHIC ex16-1_img002.jpg GRAPHIC 12399
5 GRAPHIC ex16-1_img003.jpg GRAPHIC 58746
  Complete submission text file 0001387131-19-007419.txt   161989
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 191136502
SIC: 2834 Pharmaceutical Preparations